North America pharmaceutical continuous manufacturing market is expected to grow by 9.5% annually in the forecast period and reach $851.9 million by 2030 driven by advantages offered by continuous manufacturing process such as cost saving and improved productivity.
Highlighted with 25 tables and 39 figures, this 106-page report North America Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porters Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Integrated Continuous Systems
Semi-Continuous Systems
- Continuous Granulators
- Continuous Blenders
- Continuous Compressors
- Continuous Coaters
- Continuous Dryers
- Other Semi-Continuous Systems
Controls & Software

Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
End Product Manufacturing
- Solid Dosage Manufacturing
- Liquid Dosage Manufacturing
API Manufacturing

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- Research Organizations and Institutes
- Other End Users

Geographically, the following national/local markets are fully investigated:
- U.S.
- Canada
- Mexico
Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrder Ldige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)